Factors that influence the levels of cerebrospinal fluid biomarkers in memory clinic patients
Abstract Background The cerebrospinal fluid (CSF) biomarkers amyloid β (Aβ), phospho tau (P-tau) and total tau (T-tau) are used increasingly to support a clinical diagnosis of Alzheimer’s disease. The diagnostic power of these biomarkers has been reported to vary among different studies’ results. Th...
I tiakina i:
| Ngā kaituhi matua: | , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
BMC
2017-09-01
|
| Rangatū: | BMC Geriatrics |
| Ngā marau: | |
| Urunga tuihono: | http://link.springer.com/article/10.1186/s12877-017-0611-4 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
